Free Trial

Vital Farms (NASDAQ:VITL) Stock Price Expected to Rise, Mizuho Analyst Says

Vital Farms logo with Consumer Staples background

Key Points

  • Mizuho raised its price target for Vital Farms (NASDAQ:VITL) from $45.00 to $53.00, indicating a potential upside of 14.99% from the previous close.
  • The stock has received multiple "outperform" ratings from various research analysts, with a consensus rating of "Buy" and an average target price of $47.20.
  • Vital Farms reported a 25.4% increase in quarterly revenue, with earnings per share of $0.36, surpassing analysts' expectations.
  • Looking to export and analyze Vital Farms data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Vital Farms (NASDAQ:VITL - Free Report) had its price objective boosted by Mizuho from $45.00 to $53.00 in a research note released on Monday,Benzinga reports. The brokerage currently has an outperform rating on the stock.

Several other research analysts also recently commented on the company. Telsey Advisory Group raised their target price on Vital Farms from $46.00 to $50.00 and gave the stock an "outperform" rating in a research note on Friday, August 8th. Lake Street Capital set a $60.00 price objective on Vital Farms and gave the company a "buy" rating in a report on Friday, August 8th. BMO Capital Markets reaffirmed an "outperform" rating on shares of Vital Farms in a research note on Friday, August 8th. Morgan Stanley reduced their target price on Vital Farms from $40.00 to $39.00 and set an "overweight" rating on the stock in a research note on Thursday, April 17th. Finally, Stifel Nicolaus lifted their price target on Vital Farms from $44.00 to $48.00 and gave the company a "buy" rating in a research report on Friday, August 8th. Eleven equities research analysts have rated the stock with a buy rating, According to MarketBeat, the stock has an average rating of "Buy" and an average price target of $48.20.

View Our Latest Report on Vital Farms

Vital Farms Price Performance

NASDAQ VITL remained flat at $47.75 on Monday. The company had a trading volume of 846,038 shares, compared to its average volume of 1,110,715. Vital Farms has a twelve month low of $27.91 and a twelve month high of $48.26. The stock has a market capitalization of $2.13 billion, a PE ratio of 42.63 and a beta of 0.94. The business has a 50-day moving average price of $38.07 and a two-hundred day moving average price of $35.09. The company has a quick ratio of 2.10, a current ratio of 2.48 and a debt-to-equity ratio of 0.02.

Vital Farms (NASDAQ:VITL - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.27 by $0.09. The business had revenue of $184.77 million for the quarter, compared to the consensus estimate of $170.28 million. Vital Farms had a net margin of 7.84% and a return on equity of 18.40%. The company's revenue was up 25.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.36 earnings per share. On average, research analysts expect that Vital Farms will post 1.11 EPS for the current year.

Insider Buying and Selling

In related news, CFO Thilo Wrede sold 1,200 shares of the business's stock in a transaction on Friday, July 11th. The stock was sold at an average price of $38.97, for a total transaction of $46,764.00. Following the transaction, the chief financial officer directly owned 56,187 shares in the company, valued at $2,189,607.39. The trade was a 2.09% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Matthew Ohayer sold 30,000 shares of the business's stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $39.17, for a total value of $1,175,100.00. Following the sale, the insider owned 6,858,890 shares in the company, valued at approximately $268,662,721.30. The trade was a 0.44% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 94,105 shares of company stock valued at $3,645,398. 21.30% of the stock is owned by insiders.

Institutional Trading of Vital Farms

Several large investors have recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. raised its holdings in Vital Farms by 0.4% in the 1st quarter. Envestnet Asset Management Inc. now owns 75,420 shares of the company's stock worth $2,298,000 after purchasing an additional 337 shares during the period. Summit Investment Advisors Inc. grew its position in shares of Vital Farms by 15.8% in the fourth quarter. Summit Investment Advisors Inc. now owns 3,487 shares of the company's stock valued at $131,000 after purchasing an additional 475 shares in the last quarter. Assetmark Inc. grew its position in shares of Vital Farms by 18.9% in the second quarter. Assetmark Inc. now owns 3,153 shares of the company's stock valued at $121,000 after purchasing an additional 501 shares in the last quarter. US Bancorp DE grew its position in shares of Vital Farms by 36.2% in the first quarter. US Bancorp DE now owns 1,929 shares of the company's stock valued at $59,000 after purchasing an additional 513 shares in the last quarter. Finally, Stifel Financial Corp grew its position in shares of Vital Farms by 6.8% in the fourth quarter. Stifel Financial Corp now owns 8,117 shares of the company's stock valued at $306,000 after purchasing an additional 518 shares in the last quarter. Hedge funds and other institutional investors own 98.59% of the company's stock.

About Vital Farms

(Get Free Report)

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.

Read More

Analyst Recommendations for Vital Farms (NASDAQ:VITL)

Should You Invest $1,000 in Vital Farms Right Now?

Before you consider Vital Farms, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.

While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes
3 Overlooked Stocks Riding the AI Data Center Boom

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines